Ceprotin

Generic name: Protein C Concentrate (Human)
Drug class: Miscellaneous coagulation modifiers

Usage of Ceprotin

The name of your medicine is Ceprotin, pronounced "see PRO ten".

Ceprotin contains Protein C, a natural protein that is made in the liver and is present in your blood. Protein C is a part of human plasma that regulates the blood clotting (coagulation) system and prevents abnormal clot formation (thrombosis). Plasma is the liquid part of human blood.

Ceprotin is used to treat patients with Severe Congenital Protein C Deficiency for the prevention and treatment of:

  • venous thrombosis (blood clot in the vein), and
  • purpura fulminans (blood spots, bruising and discoloring to skin as a result of clotting of small blood vessels in the skin).
  • Ceprotin side effects

    Like all medicines, Ceprotin can cause side effects, although not everyone gets them.

    The most serious and common side effects to Ceprotin observed in clinical trials were allergic reactions (rash and itching) and lightheadedness.

    There have also been individual reports, after the drug was marketed, of thoracic hematoma (bleeding into the chest), hypotension (very low blood pressure), fever, restlessness and increased sweating.

    You could develop antibodies that can prevent Ceprotin from working properly and therefore reduce its effect. This has not been seen in clinical studies.

    If you develop any side effects, including any not listed in this leaflet, please contact your doctor.

    Before taking Ceprotin

    You should not use Ceprotin unless your doctor confirms that you have severe congenital Protein C deficiency.

    You should tell your doctor about all your medical conditions.

    Allergic to Mouse Protein or Heparin: If you are known to have allergic-type reactions (rash, hives, itching, tightness of the chest, difficulty breathing, throat tightness, and low blood pressure) to mouse protein or to heparin, you should talk to your doctor before using this product. Ceprotin contains small amounts of heparin and/or mouse protein as a result of the manufacturing process. If such a reaction occurs, you should discuss this with your doctor and your doctor will decide the right treatment.

    Low Sodium Diet/Kidney Impairment: You should talk with your doctor before using Ceprotin if you are on a low sodium diet or have problems with your kidney, as the amount of sodium in the maximum daily dose of Ceprotin exceeds 200 mg.

    Pregnancy or Breast-feeding: You should inform your doctor if you are pregnant or breast-feeding. Your doctor will decide if Ceprotin may be used during pregnancy and/or breast-feeding.

    Tell your doctor about all the medicines you are taking including prescription and nonprescription medicines, vitamins, and herbal supplements. You should also tell your doctor if you are on a special diet.

    Relate drugs

    How to use Ceprotin

    Ceprotin is given by intravenous administration (infusion into a vein). It is given to you under the close supervision of your doctor who is experienced in replacement therapy of coagulation factors/inhibitors and where monitoring of protein C activity is possible. Your dosage will vary depending upon your condition, your age and your body weight. Your doctor may require that you have blood taken to help determine the dose of Ceprotin that you should get. See following Instructions for Use.

    BLUE COLOR BAR: Approximate dosage strength of 500 IU per vial. GREEN COLOR BAR: Approximate dosage strength of 1000 IU per vial.

    Warnings

    The most serious and common adverse reactions observed in clinical trials were rash, itching and lightheadedness.

    The following adverse reactions have been identified during postapproval use of Ceprotin: hemothorax, hypotension, hyperhydrosis, fever and restlessness.

    Patients on low sodium/renal impairment diet should be informed that the quantity of sodium in the maximum daily dose of Ceprotin exceeds 200mg.

    Ceprotin contains trace amounts of heparin, which may lead to Heparin- induced Thrombocytopenia.

    As with all plasma-derived therapeutics, the potential to transmit infectious agents (e.g. viruses) cannot be totally eliminated.

    Source: Baxter International Inc.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords